Erin Fuse Brown weighs in on the potential impact of the FTC's new rules against noncompete agreements, analyzing how this significant shift could empower healthcare workers and reshape the dynamics of the industry.

Amidst a silent surge of corporate takeovers in healthcare, Yashaswini Singh offers crucial insights into how these acquisitions are quietly transforming patient care and escalating costs, often beyond the public eye.

This article discusses Oregon's successful experiment in implementing price caps on hospital services, saving $107.5 million in two years, suggesting a viable solution for states battling soaring healthcare costs.

Under the CMS 2025 Medicare Advantage Advance Notice, CAHPR researchers emphasize the expected revenue increases and minor changes in risk adjustment practices; highlighting the impactful changes on the horizon and the critical reforms that still await attention.

Congress has a critical opportunity to advance healthcare price transparency, a move that could empower consumers and reduce costs across the system. This article explores the current state of healthcare price transparency and the critical role Congress plays in shaping a system that prioritizes clarity and fairness for all Americans.

Rev Cycle Management, an information avenue for revenue cycle management writes on the Health Affairs study led by Brown researchers on the impact of hospital payment caps in Oregon and the health savings achieved for the state.

Oregon bill, HB 4130, aims to impose some of the strictest limits on corporate ownership of primary care and specialty clinics, targeting the influence of large companies and private equity firms.

This article looks at how private equity firms are increasingly employing "straw doctors" to circumvent restrictions on corporate ownership of medical practices -- threatening the quality of patient care and the integrity of the medical profession.

Ashish Jha casts a critical eye on the influence of private equity in healthcare, illuminating how these acquisitions not only escalate costs but also fundamentally reshape the quality and accessibility of medical care.

Associate Professor of Health Services, Policy & Practice, Dr. Chris Whaley's 2023 publication along with other colleagues "What’s Behind Losses At Large Nonprofit Health Systems? " gets recognized as one of the top ten most read Health Affairs Forefront articles in 2023.

Read this NPR article or listen to the All Things Considered NPR broadcast featuring Dr. David Meyers where he talks about the difficulties a beneficiary can face when enrolled in Medicare Advantage.

Yashaswini Singh and Christopher Whaley comment on the escalating presence of private equity in healthcare, exploring the compelling reasons doctors are selling their practices and the profound ripple effects this trend casts across the health care landscape.

Payer-led consolidation is understudied but a growing trend. Read Dr. Yashaswini Singh's thoughts on the corporization of healthcare.

Dr. Yashaswini Singh comments on the newly released health policy efforts by the Biden Administration on lowering drug prices and improving ownership transparency

Brown and Lifespan aim to strengthen their partnership in 2024. Read here to learn more about this potential partnership.

Dr. Chris Whaley is featured in this LA Times article, discussing the situation of the MLK Community Hospital as it faces financial turmoil and potential closure due to funding challenges

Dr. David Meyers, Associate Director for the Center for Advancing Health Policy Through Research and Assistant Professor of Health Services, Policy & Practice was presented with the award to mark his contributions and mentorship in the field.

Dr. Chris Whaley along with other experts discuss strategies for greater healthcare price transparency and cost control in New Hampshire

Learn more about the global economic impact of COVID-19 vaccinations

Dr. Christopher Whaley and Erin Fuse Brown from CAHPR give their thoughts on General Catalyst, a VC firm which unusually plans to buy a health system

What is the future of private equity in US Healthcare? Read this article to see what the experts at CAHPR think.

Watch the full discussion from our launch event

A unique lawsuit filed by the Federal Trade Commission that alleges a private equity sponsor and the company of creating a monopoly.

Listen to Drs. Ehsan Rahimy, Yashaswini Singh, and Jane Zhu in this podcast exploring the correlation between private equity acquisition of ophthalmology practices and a rise in healthcare expenditures